Skip to main content
Equibles

FEDERATED HERMES, INC.

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1056288 PITTSBURGH, PA
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$29,487,771
+$4,107,362 QoQ
Shares Held
1,124,629
+4.4% QoQ
Ownership
0.895%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#26
of 271 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. ARQT ranks #26 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 719,905 $216,713,000
2 RYTM
Rhythm Pharmaceuticals, Inc.
 1,785,716 $198,268,046
3 REGN
Regeneron Pharmaceuticals, Inc.
 256,884 $160,177,448
4 MRNA
Moderna, Inc.
 1,794,778 $125,688,301
5 KYMR
Kymera Therapeutics, Inc.
 749,398 $85,933,468
6 EYPT
EyePoint, Inc.
 5,681,052 $81,239,042
7 ARGX
Argenx SE
 87,288 $80,983,187
8 ZBIO
Zenas BioPharma, Inc.
 3,116,805 $79,104,510

All Filings in ARQT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,487,771 1,124,629
2026-03-31 $25,380,409 1,077,267
2025-12-31 $25,896,912 891,767
2025-09-30 $14,317,950 759,573
2025-06-30 $10,337,911 737,369
2025-03-31 $11,535,359 737,555
2024-12-31 $6,866,401 492,922
2024-09-30 $4,667,026 501,831
2024-06-30 $3,256,060 350,114
2024-03-31 $3,469,629 350,114
2023-12-31 $1,684,344 521,469
2023-09-30 $318,600 60,000
2023-06-30 $381,200 40,000
2023-03-31 $330,000 30,000
2022-12-31 $355,200 24,000